Keywords: update, genzyme, pay, 345m, clofarabine, co-development, partner

UPDATE: Genzyme to pay $345M for clofarabine to co-development partner Bioenvision

Article | 04 June 2007

Massachusetts, USA-based biotechnology major Genzyme Corp says that it has reached agreement to acquire Bioenvision, headquartered in New York, in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Clofarabine

Clolar

Cytarabine

Go to drug listing